Controlled Active Ingredient Delivery via Textiles

Controlled Active Ingredient Delivery via Textiles

 

 

Executive Summary:

Textile-Based Delivery, Inc. (TexDel) has developed a proprietary technology that will combine the $300B Athleisure market with the $1.7 trillion health and wellness market to redefine the nature of competitive advantage in the apparel industry. More than 85% of adults believe that good heath contributes to their definition of overall success. Instead of applying a cream, taking a pill or using a patch, you’ll only need to get dressed. Now, clothing can be transformed to deliver performance improving, healing, and aesthetic capabilities through 10s or even 100s of washings. TexDel “smart” textiles deliver drugs and actives to (dermal delivery) and through (transdermal) the skin. TexDel is innovating, testing, and scaling-up production through combined expertise in both drug- delivery and advanced textiles via fabrics, linens, dressings and other materials, in a manner uniquely informed by the quality standards and practices of the Pharmaceutical industry.

TexDel’s drug-loaded, texturized yarns have been shown compatible with production-scale knitting and weaving machines, and we are now developing and scaling production processes of our “ActiveYarn” in conjunction with prospective manufacturing partners. We are also expanding the range of drugs and OTC actives formulated and tested for release. We are partnering with American yarn and textile manufacturers to convert our proprietary, patent- pending technology into garments and dressings for proven and measurable front-line improvements in health and well-being.